A case of transfusion-associated graft-versus-host disease not prevented by white cell-reduction filters.
about
Leucoreduction of blood components: an effective way to increase blood safety?Risks, costs, and alternatives to platelet transfusions.Leucocyte depletion of the blood supply - how will patients benefit?Revisitation of the clinical indications for the transfusion of platelet concentrates.Transfusion-associated graft-versus-host disease.Prevention of transfusion-associated graft-versus-host disease by irradiation: technical aspect of a new ferrous sulphate dosimetric system.Guidelines for assessing appropriateness of pediatric transfusion.Novel processes for inactivation of leukocytes to prevent transfusion-associated graft-versus-host disease.Absence of transfusion-associated microchimerism in pediatric and adult recipients of leukoreduced and gamma-irradiated blood components.Developments in the prevention of transfusion-associated graft-versus-host disease.Umbilical cord blood transplantation: review of factors affecting the hospitalized patient.Transfusion-associated graft versus host disease in the immunocompetent patient: an ongoing problem.Altered homeostatic regulation of innate and adaptive immunity in lower gastrointestinal tract GVHD pathogenesis.Analysis of 66 patients definitive with transfusion-associated graft-versus-host disease and the effect of universal irradiation of blood.The platelets' perspective to pathogen reduction technologies.Understanding loss of donor white blood cell immunogenicity after pathogen reduction: mechanisms of action in ultraviolet illumination and riboflavin treatment.The quality of red blood cells.HLA homozygosity and shared HLA haplotypes in the development of transfusion-associated graft-versus-host disease.Irradiation in the prevention of transfusion associated graft-versus-host disease.Diagnosis of transfusion-associated graft-vs.-host disease: the importance of short tandem repeat analysis.In vitro and in vivo measurements of gamma-radiated, frozen, glycerolized RBCs.Transfusion-associated graft-versus-host disease in a patient with Waldenstrom's macroglobulinaemia.Broadening the spectrum of patient groups at risk for transfusion-associated GVHD: implications for universal irradiation of cellular blood components.Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease?Immune modulation and lack of alloimmunization following transfusion with pathogen-reduced platelets in mice.Prevention of transfusion-associated graft-versus-host disease with pathogen-reduced platelets with amotosalen and ultraviolet A light: a review.The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion-associated graft-versus-host disease.Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells.Leukoreduction of blood transfusions does not diminish transfusion-associated microchimerism in trauma patients.Effect of recipient immune status on the persistence and clinical consequences of transfused leucocytesTransfusion-associated GVHD: 10 years' experience at the American University of Beirut-Medical Center
P2860
Q26771857-C0D50892-4DA5-462F-A5D3-E70C56AC6174Q33328995-E6008955-263C-4395-820C-16D314C75321Q34022474-01E5C64E-2BF8-455E-B605-30F5CA8EDF1EQ34434805-366B360E-C9FA-4854-8F94-AD587F170F84Q34612190-38267721-F429-4B36-A355-DF1C741C18F1Q34769815-F2592937-D199-4EA9-997D-6F5BE7AE3340Q34991606-D5C9EE79-1E9D-4DB6-89BB-A21D012E8615Q35597052-15A7FF1D-AC0B-4CE6-9EA9-BC93C8C046C9Q35670166-768C6822-591F-403B-8541-B4A21756A161Q38021811-53D6AA71-97A0-43A3-992E-EBEBB35289FBQ38113482-F1C7A20E-3346-41CB-9ABE-A6B9188F607CQ38116361-08A85580-EEA7-40FC-B940-3FD174B62375Q38743931-C9C6E5C2-001F-4027-B1DB-567A2C466348Q40227144-DC37E39F-FF55-4FAD-AF2F-EA892133A53CQ40273685-13A7291F-ABDC-4E49-8A54-10ED5476D087Q40384711-1FEDB9D0-1EE6-4DF0-B17C-D257CF9B0CA2Q40505308-46BAE977-40BF-48C5-8ECF-54C0B5E6944BQ40599148-B2693E41-C5A9-4512-AD88-62CB9B24BF8BQ40941673-705095AE-C083-4CE4-A404-3C52ED2A4ED3Q42675872-EF5FEDB0-76C9-415A-8A6E-2EF38472CFC2Q43584981-CCE98A17-5E81-4A6E-8E5A-0FA72B933EF1Q44169622-127C9E61-EF94-49AB-AB1A-E8D9187CC504Q45280220-E7D0BCD7-3568-4891-8157-9221E6C83EE9Q46505820-53D756E5-3013-4980-9328-06C3C8549476Q46772168-419C33A1-215C-48CF-B313-012281684FC7Q48193795-A7C3BE07-C1BA-4F14-AF5E-538C77700D70Q50686453-945847EC-F192-495A-9482-9258D5E39424Q50733352-D420E648-137F-4EE1-A344-3EAC3926270CQ54573429-E90B805C-6332-498C-A2EE-52B4C61D464DQ57937727-0A3C8E93-824D-438B-9498-B06D8B528A9AQ57998518-AC6685CB-78FC-4CEC-B5DA-C76C7899DEF0
P2860
A case of transfusion-associated graft-versus-host disease not prevented by white cell-reduction filters.
description
1992 nî lūn-bûn
@nan
1992 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
A case of transfusion-associat ...... white cell-reduction filters.
@ast
A case of transfusion-associat ...... white cell-reduction filters.
@en
type
label
A case of transfusion-associat ...... white cell-reduction filters.
@ast
A case of transfusion-associat ...... white cell-reduction filters.
@en
prefLabel
A case of transfusion-associat ...... white cell-reduction filters.
@ast
A case of transfusion-associat ...... white cell-reduction filters.
@en
P2093
P1433
P1476
A case of transfusion-associat ...... white cell-reduction filters.
@en
P2093
Akahoshi M
Hasegawa K
Kasajima T
Takanashi M
Yamashita H
P304
P356
10.1046/J.1537-2995.1992.32292180149.X
P577
1992-02-01T00:00:00Z